Search results
Results from the WOW.Com Content Network
Alpidem (Ananxyl) 1995. Worldwide. Not approved in the US, withdrawn in France in 1994 [ 4] and the rest of the market in 1995 because of rare but serious hepatotoxicity. [ 3][ 5] Alosetron (Lotronex) 2000. US. Serious gastrointestinal adverse events; ischemic colitis; severe constipation. [ 2] Reintroduced 2002 with restricted indication and ...
Osteoporosis, including drug- and cancer-related osteoporosis, giant cell tumour of bone and hypercalcaemia of malignancies: Hypercholesterolaemia, cataract, urinary retention, hypocalcaemia, osteonecrosis of the jaw and anaphylaxis. Gemtuzumab ozogamicin: IV: CD33 antibody that induces apoptosis of the tagged cell. Acute myeloid leukaemia
The U.S. Food and Drug Administration (FDA) has approved a new drug for certain adult patients with endometrial cancer. Jemperli (dostarlimab-gxly) — made by British pharmaceutical company GSK ...
Headquarters. Diliman, Quezon City, Metro Manila. Government agency executive. Sec. Catalino Cuy, Chairman. Parent department. Office of the President of the Philippines. Website. www .ddb .gov .ph. The Dangerous Drugs Board ( Filipino: Lupon sa Mapanganib na Droga, abbreviated DDB) is a government agency tasked in creating policies in dealing ...
The history of medicine in the Philippines discusses the folk medicinal practices and the medical applications used in Philippine society from the prehistoric times before the Spaniards were able to set a firm foothold on the islands of the Philippines for over 300 years, to the transition from Spanish rule to fifty-year American colonial embrace of the Philippines, and up to the establishment ...
For premium support please call: 800-290-4726 more ways to reach us
Aromatase inhibitors ( AIs) are a class of drugs used in the treatment of breast cancer in postmenopausal women and in men, [ 1][ 2] and gynecomastia in men. They may also be used off-label to reduce estrogen conversion when supplementing testosterone exogenously. They may also be used for chemoprevention in women at high risk for breast cancer.
Substance abuse prevention, also known as drug abuse prevention, is a process that attempts to prevent the onset of substance use or limit the development of problems associated with using psychoactive substances. Prevention efforts may focus on the individual or their surroundings.